Biostax Corp (BTAX)

[noreen]

I believe we are waiting for NACA approval in Nigeria. It talks about it in the December shareholder letter.

Until then, the AHAR sales of $195k that were shipped in February are not being sold for HIV. They are being sold for cancer, from my understanding, and can’t be sold as an HIV drug until NACA approval is granted.

This is my understanding, someone please correct me if I’m wrong.

Likewise, in Kenya, we’re still awaiting approval from NASCOP and the Pharmacy and Poison Board.